(Reuters) - Eli Lilly said on Monday that it will acquire a manufacturing facility from Nexus Pharmaceuticals to produce injectable medicines. Lilly expects production at the facility based in Pleasant Prairie, Wisconsin, to begin at the end of 202.
'Implied Disease Claims' Preempted by FDCA, Calif. Federal Judge Rules harrismartin.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from harrismartin.com Daily Mail and Mail on Sunday newspapers.
MON AM News: Nexus Pharmaceuticals aims to grow Pleasant Prairie footprint as it adds drug lines; Marquette nursing school integrating Epic platform into curriculum wisbusiness.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wisbusiness.com Daily Mail and Mail on Sunday newspapers.
Nexus Pharmaceuticals aims to grow Pleasant Prairie footprint as it adds drug lines wisbusiness.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wisbusiness.com Daily Mail and Mail on Sunday newspapers.